Skip to main content

Cost-efficient European adaptations of global health economic models

Experience with model adaptations in Austria, Belgium, France, Germany, Italy, Norway, Netherlands, Spain, Sweden, the UK

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Update of the National Genomic Test Directory for cancer in England

25 May 2023

On May 17, 2023, NHS England issued an updated version of the National Genomic Test Directory for cancer (version 7), which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs.

Two new codes (test-indication combinations) were introduced in the Test Directory for cancer for multi-target NGS panel-small variant (BRCA1, BRCA2) germline testing in breast and prostate cancer.

The document specifying eligibility criteria for rare and inherited diseases Directory was also updated (version 5.1); however, no new codes were added, and only minor amendments were made.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.